Patent · US Active

Uses of anti-SIRPg antibodies

US12331115B2 · kind B2 · utility

0Cited by
0References
3Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 9, 2022
Grant dateJun 17, 2025
Priority date
Expiry dateMar 6, 2042

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/52
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention pertains to the field of immunotherapy. The present invention provides new uses of anti-SIRPg antibodies for the treatment and/or the prevention of autoimmune disorders or diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.